Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can mitomycin C really prevent airway stenosis?

Jong-Lyel Roh1, Yong-Won Lee, Chan Il Park

  • 1Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. happyfam@paran.com

The Laryngoscope
|March 17, 2006
PubMed
Summary

Mitomycin C (MMC) treatment for subglottic stenosis in rabbits delayed wound healing and increased airway obstruction risk. The study suggests caution when using MMC clinically due to these complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Membrane instability as a propagation-repair imbalance in ferroptosis.

Free radical biology & medicine·2026
Same author

Inducing Ferroptosis to Enhance Radiotherapy in Head and Neck Cancer: Mechanisms, Radiosensitization Strategies, and Normal Tissue Considerations.

Cells·2026
Same author

Ferroptosis in Differentiated Thyroid Cancer: Redox-Iodine Metabolism, Dedifferentiation, and Therapeutic Sensitization Beyond Anaplastic Disease.

Cells·2026
Same author

Metabolic Flux Adaptations During GLP-1 Receptor Agonist Therapy: Redox Implications.

Current obesity reports·2026
Same author

Ferroptosis in salivary gland disorders: mechanisms, biomarkers, and therapeutic perspectives.

Apoptosis : an international journal on programmed cell death·2026
Same author

Membrane Stress and Ferroptosis: Lipid Dynamics in Cancer.

International journal of molecular sciences·2026

Area of Science:

  • Otolaryngology
  • Regenerative Medicine
  • Surgical Innovation

Background:

  • Mitomycin C (MMC) is utilized to prevent upper airway stenosis.
  • Its clinical efficacy remains debated, with limited data on complications.
  • Subglottic stenosis presents a significant clinical challenge.

Purpose of the Study:

  • To evaluate the efficacy and early complications of Mitomycin C (MMC) in a rabbit subglottic wound model.
  • To assess the impact of MMC on wound healing and stenosis development.

Main Methods:

  • A randomized animal study involving 60 rabbits with laser-induced subglottic injury.
  • Animals were treated with topical Mitomycin C (MMC) at 0.4 or 10 mg/mL, or saline.
  • Outcomes were assessed at 4 weeks, comparing wound healing, stenosis, and complications.

Related Experiment Videos

Main Results:

  • A higher mortality rate (67%) was observed in MMC-treated groups due to airway obstruction, compared to controls (25%).
  • Mitomycin C (MMC) significantly delayed subglottic wound healing.
  • The degree of stenosis was similar across groups, but collagen deposition was reduced with MMC.

Conclusions:

  • Subglottic laser wounding combined with Mitomycin C (MMC) treatment carries a significant risk of acute airway obstruction.
  • Delayed wound healing is a key complication associated with MMC use in this model.
  • Clinical application of MMC for subglottic stenosis warrants careful consideration of these risks.